(All fields required)
Please enter a valid email.
Please enter your name.
Groundbreaking treatments for sickle cell disease and cystic fibrosis. Heart assist devices and other improvements in organ transportation. Bold steps in understanding pediatric cancers. These are just some of the many outstanding research projects underway at Cincinnati Children's. Read our Research Annual Report.
The anti-rejection drug everolimus continues to show promise at reducing disease-related brain tumors.Read More »
100-gene expression test may help stratify patients with septic shock according to the severity.Read More »
TRPC inhibitors may have implications for heart failure, muscular dystrophy and other conditions.Read More »
Updated findings reinforce the need to intervene early for teens with high blood pressure, high cholesterol or diabetes.Read more »
Cincinnati Children's one of three nationwide to be named an NIH Center of Excellence in pediatric nephrology.Read More »
Cincinnati Children's and Boston Children's to share NIH Center of Excellence grant to study autism.Read More »
Register today for Pediatric Insights, our monthly e-newsletter for physicians. Receive the latest information on clinical advancements, research updates and news from Cincinnati Children's.
Subscribe Now >>
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2014 Cincinnati Children's Hospital Medical Center